ReviewJournal of diabetes and metabolic disorders2025
Zebrafish as an effective model for accelerating diabetes research from discovery to therapy.
Review in Journal of diabetes and metabolic disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Diabetes is a global health crisis affecting over 422 million people, necessitating innovative research models. Zebrafish ( Methods: A comprehensive literature search was conducted across PubMed, Scopus, and Web of Science, focusing on studies involving zebrafish models of Type 1 and Type 2 diabetes. Included publications were evaluated based on their methodology (e.g., surgical, chemical, genetic, or dietary induction of diabetes), reproducibility, and relevance to diabetic pathophysiology and complications. Results: Zebrafish models effectively replicate core diabetic features, including hyperglycemia, insulin resistance, and β-cell dysfunction. Their transparent embryos and larvae facilitate real-time visualization of metabolic and vascular changes. Furthermore, zebrafish support the study of diabetes-related complications-such as retinopathy, nephropathy, neuropathy, and cardiomyopathy-through genetic modifications and pharmacological interventions. Studies have demonstrated the efficacy of antidiabetic drugs, including metformin and glimepiride, using these models. Conclusion: Despite challenges (e.g., physiological differences from mammals), zebrafish bridge mechanistic discovery and translational applications, accelerating diabetes research. Their cost-effectiveness, rapid development, and screening potential underscore their critical role in understanding diabetes and developing targeted therapies to address this global health burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.